# Ph2 Study for Optimization of Adjunct Systemic Therapy in HER2+ Patients, MolecularPCR Trial

> clinical trial · VERIFIED · 2026-06-24

Status: RECRUITING · Sponsor: M.D. Anderson Cancer Center · Condition: Anatomic Stage I Breast Cancer AJCC v8

- Company: M.D. Anderson Cancer Center
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT07407920

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.